Neurotech International Ltd Suite 102/ Level 1, 55 Collins Street, Melbourne VIC 3000 T: 03 9498 3132 E: info@neurotechinternational.com W: neurotechinternational.com ABN: 73 610 205 402 ASX: NTI 1 of 1 1 October 2026 Dear Shareholder, ANNUAL GENERAL MEETING – NOTICE AND PROXY FORM Notice is...
Neurotech International: Notice of Annual General Meeting/Proxy Form
Filed with ASX · · 28 pages · English
Summary by 6ix AI
Neurotech International Ltd. has issued a notice for its upcoming Annual General Meeting, detailing the agenda and resolutions to be voted on by shareholders. The meeting is scheduled to take place at a specified location and time, with provisions for proxy voting and participation. Key resolutions include the adoption of the remuneration report, election of directors, and approval for share issuances under various mandates. Shareholders are encouraged to read the notice thoroughly and seek professional advice if needed before voting.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Release
Neurotech International Ltd. on 6ix
Earlier from Neurotech International
- NTI Doses First Patient in Phase 3 Beyond Harmony ASD Study
- Initial Director's Interest Notice
- Notification of cessation of securities - NTI
- Board and Management Changes
- Final Director's Interest Notice
Later from Neurotech International
- Annual Report (Typeset)
- Change of Director's Interest Notice
- Becoming a substantial holder
- Corporate Presentation
- Ceasing to be a substantial holder
Follow Neurotech International into a list and get an email when it puts out news.
Follow Neurotech International